| Title |
Author |
Type |
Date |
Words |
| Taysha Gene Therapies receives orphan drug designation for TSHA-120. |
|
|
May 3, 2022 |
249 |
| Hydrogen-Rich Water Improves Cognitive Ability and Induces Antioxidative, Antiapoptotic, and Anti-Inflammatory Effects in an Acute Ischemia-Reperfusion Injury Mouse Model. |
Lee, Dain; Choi, Jong-Il |
Report |
Oct 27, 2021 |
8561 |
| VICO Therapeutics receives orphan-drug designation from FDA for VO659. |
|
|
Jul 29, 2021 |
181 |
| VICO Therapeutics receives orphan-drug designation from FDA for VO659. |
|
|
Jul 29, 2021 |
182 |
| MEMORY: Blood-brain barrier-crossing antihypertensives linked with better recall. |
Pass, Will |
|
Jul 1, 2021 |
973 |
| Memory benefit seen with antihypertensives crossing blood-brain barrier. |
Pass, Will |
|
Jul 1, 2021 |
1146 |
| Clene presents updated blinded efficacy data from Phase 2 RESCUE-ALS study. |
|
|
May 12, 2021 |
321 |
| Rational design and synthesis of quinazoline derivatives. |
AlKharaz, Fatimah; Abudayeh, Zead; Abualassal, Qais; Hassouneh, Loay |
|
Apr 1, 2021 |
3624 |
| Rational design and synthesis of quinazoline derivatives. |
AlKharaz, Fatimah; Abudayeh, Zead; Abualassal, Qais; Hassouneh, Loay |
|
Apr 1, 2021 |
3537 |
| Boehringer Ingelheim, The Lieber Institute for Brain Development to Collaborate to Develop Centrally Acting COMT Inhibitors for Treatment of Neuropsychiatric Disorders. |
|
Disease/Disorder overview |
Mar 16, 2021 |
284 |
| BIOGEN AND SAGE THERAPEUTICS COLLABORATE. |
|
|
Jan 1, 2021 |
1051 |
| Hydrogen-Rich Water Improves Cognitive Ability and Induces Antioxidative, Antiapoptotic, and Anti-Inflammatory Effects in an Acute Ischemia-Reperfusion Injury Mouse Model. |
Lee, Dain; Choi, Jong-Il |
Report |
Jan 1, 2021 |
8559 |
| Evaluation of Anticonvulsant Activity of 80% Methanolic Root Bark Extract and Solvent Fractions of Pentas schimperiana (A. Rich.) Vatke (Rubiaceae) in Swiss Albino Mice. |
Fisseha, Nebeyi; Shibeshi, Workineh; Bisrat, Daniel |
|
Jan 1, 2021 |
4287 |
| BrainEver Receives FDA Orphan Drug Designation for BREN-02 for the Treatment of Amyotrophic Lateral Sclerosis. |
|
|
Nov 27, 2020 |
453 |
| US FDA Accepts Biohaven's Supplemental New Drug Application of Nurtec ODT for the Preventive Treatment of Migraine. |
|
|
Oct 15, 2020 |
493 |
| Bioasis has the best platform technology for shuttling drugs across the blood-brain barrier. |
|
|
Oct 10, 2020 |
1194 |
| US FDA Grants Orphan Drug Designation to Ionis Treatment for Alexander Disease. |
|
|
Oct 1, 2020 |
412 |
| A Multifaceted Evaluation of National Off-label Neurology Applications/Ulusal Endikasyon Disi Noroloji Basvurularinin Cok Yonlu Degerlendirilmesi. |
Yurtogullari, Sukran; Rahmanlar, Hanife; Alkan, Ali; Bayar, Banu; Gursoz, Hakki; Adatepe, Nurten Uzu |
Report |
Sep 1, 2020 |
4186 |
| Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment. |
Cvenkel, Barbara; Kolko, Miriam |
|
Aug 31, 2020 |
12683 |
| Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease. |
Nieto-Aristizabal, Ivana; Vivas, Alvaro J.; Ruiz-Montano, Pablo; Aragon, Cristian C.; Posso-Osorio, |
|
Aug 31, 2020 |
4652 |
| Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin. |
|
|
Jul 13, 2020 |
212 |
| New drug good news for schizophrenia patients. |
|
|
Mar 12, 2020 |
467 |
| Neuren Pharmaceuticals secures Rare Pediatric Disease designation for trofinetide to treat Rett Syndrome. |
|
|
Mar 5, 2020 |
389 |
| NeuroSense Therapeutics wins ODD for ALS drug PrimeC and announces two clinical studies in ALS. |
|
Clinical report |
Feb 10, 2020 |
269 |
| NeuroSense Therapeutics wins ODD for ALS drug PrimeC and announces two clinical studies in ALS. |
|
Clinical report |
Feb 10, 2020 |
265 |
| Novel Drug For Schizophrenia To Hit The Market. |
Seema Prasad |
|
Dec 25, 2019 |
586 |
| ITF Pharma wins FDA approval for expanding the existing label of TIGLUTIK to include administration via percutaneous endoscopic gastrostomy (PEG) tubes in ALS patients. |
|
|
Dec 16, 2019 |
301 |
| ITF Pharma wins FDA approval for expanding the existing label of TIGLUTIK to include administration via percutaneous endoscopic gastrostomy (PEG) tubes in ALS patients. |
|
|
Dec 16, 2019 |
297 |
| Neurodegenerative Disease Deaths Up in Former Soccer Players; Former Scottish soccer players also more often prescribed dementia-related medications than controls. |
|
|
Oct 23, 2019 |
270 |
| A drug invented for just one patient. |
Gina Kolata |
|
Oct 11, 2019 |
1013 |
| Annexon Biosciences' ANX005 granted US FDA fast track designation. |
|
|
Sep 25, 2019 |
127 |
| Annexon Biosciences' ANX005 granted US FDA fast track designation. |
|
|
Sep 25, 2019 |
123 |
| Global Central Nervous System Diseases Drug Delivery Research Report 2019. |
|
Report |
Aug 12, 2019 |
869 |
| Quantitative Structure-Activity Relationship Analysis of Selective Rho Kinase Inhibitors as Neuro-regenerator Agents/Noro-rejenerator Ajan Olarak Secici Rho Kinaz Inhibitorlerinin Kantitatif Yapi-Etkinlik Iliski Analizi. |
Kesar, Seema; Paliwal, Sarvesh K.; Mishra, Pooja; Chauhan, Monika |
Report |
May 17, 2019 |
6660 |
| New treatment to stop seizures sparks hope ahead of Purple Day. |
|
|
Mar 23, 2019 |
616 |
| Iranian Scientists Use Nano-Conductors for Smart Treatment of Diabetes. |
|
|
Dec 12, 2018 |
610 |
| H. Lundbeck and Otsuka report positive clinical phase II data for the combination treatment of brexpiprazole and sertraline for treatment of PTSD. |
|
Disease/Disorder overview |
Dec 3, 2018 |
426 |
| H. Lundbeck and Otsuka report positive clinical phase II data for the combination treatment of brexpiprazole and sertraline for treatment of PTSD. |
|
Disease/Disorder overview |
Dec 3, 2018 |
422 |
| H Lundbeck reports on clinical phase III study for Lu AF35700 in treatment-resistant schizophrenia. |
|
|
Oct 26, 2018 |
218 |
| H Lundbeck reports on clinical phase III study for Lu AF35700 in treatment-resistant schizophrenia. |
|
|
Oct 26, 2018 |
219 |
| H Lundbeck reports on clinical phase III study for Lu AF35700 in treatment-resistant schizophrenia. |
|
|
Oct 26, 2018 |
214 |
| First Patient Dosed in Phase 2 Study of Karuna's Lead Product Candidate KarXT for the Treatment of Schizophrenia. |
|
|
Oct 15, 2018 |
698 |
| Neurocrine Biosciences partners with Jnana Therapeutics to discover novel medicines to treat central nervous system disorders. |
|
|
Oct 10, 2018 |
246 |
| Neurocrine Biosciences partners with Jnana Therapeutics to discover novel medicines to treat central nervous system disorders. |
|
|
Oct 10, 2018 |
242 |
| FDA Grants Orphan Drug Designation for AMO Pharma's Rett Syndrome Treatment. |
|
|
Jun 18, 2018 |
195 |
| Airway Dimensions in Children with Neurological Disabilities During Dexmedetomidine and Propofol Sedation for Magnetic Resonance Imaging Study/Norolojik Disabilitesi olan Cocuklarda Manyetik Rezonans Goruntuleme Calismasinda Deksmedetomidin ve Propofol ile Sedasyon Suresince Havayolu Boyutlari. |
Sriganesh, Kamath; Saini, Jitender; Theerth, Kaushik; Venkataramaiah, Sudhir |
Report |
Jun 1, 2018 |
4398 |
| Evaluation of anticonvulsant activity of Saraca asoca flower (Roxb.) Wilde in Swiss albino mice. |
Srinivasa, K.; Kumara, Shashi; Neetha, C.S. |
Report |
Jun 1, 2018 |
3144 |
| Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level. |
Gunaydin, Caner; Bilge, S. Sirri |
Report |
Jun 1, 2018 |
5151 |
| The Role of Ionic Homeostasis in Cisplatin-Induced Neurotoxicity: A Preliminary Study. |
Unel, Cigdem Cengelli; Erol, Kevser |
Report |
Jun 1, 2018 |
4484 |
| Old drug, new usage! |
|
|
May 18, 2018 |
359 |
| Aggressive outbursts and emotional lability in a 16-year-old boy. |
Capote, Horacio A.; Asbach, Michael T. |
Case study |
May 1, 2018 |
2604 |
| Anti-depressants and bladder drugs could increase risk of developing dementia; A British Medical Journal study found a link between some anticholinergic drugs and long-term memory or thinking problems. |
|
|
Apr 26, 2018 |
547 |
| Promising New Treatment for ALS: Pimozide, a 50-year-old drug used to treat schizophrenia, may inhibit progression of amyotrophic lateral sclerosis (ALS). |
|
|
Apr 1, 2018 |
553 |
| First Patient Enrolled in Biohaven Phase 3 Clinical Trial Evaluating Oral Dissolving Form of Rimegepant in Acute Treatment of Migraine. |
|
|
Mar 7, 2018 |
321 |
| VA Adds New ALS Drug. |
|
|
Feb 1, 2018 |
190 |
| Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease. |
Nascimento-Castro, Cristine de Paula; Wink, Ana Claudia; da Fonseca, Victor Silva; Bianco, Claudia D |
|
Jan 1, 2018 |
11652 |
| Successful Treatment of Unknown Drug-Induced Catatonia with Intravenous Midazolam in a Nine-Year-Old Girl. |
Oguz, Sinan; Tuygun, Nilden; Kesici, Selman; Karacan, Can Demir |
Clinical report |
Jan 1, 2018 |
1512 |
| ICBII files orphan drug designation application with the US FDA for I[+ or -]-Synuclein-SMART Molecule for multiple system atrophy. |
|
|
Dec 6, 2017 |
212 |
| ICBII files orphan drug designation application with the US FDA for I[+ or -]-Synuclein-SMART Molecule for multiple system atrophy. |
|
|
Dec 6, 2017 |
216 |
| Biohaven's Second Efficacy and Safety Trial of Rimegepant for Acute Treatment of Migraine Completes Enrollment. |
|
|
Nov 28, 2017 |
327 |
| Biohaven Completes Enrollment in Safety and Efficacy Trial of Rimegepant for Acute Treatment of Migraine. |
|
|
Nov 17, 2017 |
264 |
| Hydra Biosciences and Boehringer Ingelheim Collaboration Initiates Clinical Trial of TRPC4/5 Inhibitor for CNS Disorders. |
|
|
Nov 3, 2017 |
244 |
| Eugenol efficacy in preventing nicotine-induced seizures in mice. |
Karampour, Neda Sistani; Arzi, Ardeshir; Namazifar, Soroor |
Report |
Nov 1, 2017 |
2664 |
| Lithium Chloride can Induce Differentiation of Human Immortalized RenVm Cells into Dopaminergic Neurons. |
Soleimani, Mitra; Ghasemi, Nazem |
Report |
Oct 1, 2017 |
2647 |
| UCB's new antiepileptic drug BRIVIACT approved by US FDA as monotherapy treatment for partial-onset seizures in adults. |
|
|
Sep 15, 2017 |
310 |
| UCB's new antiepileptic drug BRIVIACT approved by US FDA as monotherapy treatment for partial-onset seizures in adults. |
|
|
Sep 15, 2017 |
306 |
| Marshall University School of Medicine approved for neurology residency program. |
Ferguson, Paul |
Report |
Sep 1, 2017 |
307 |
| Mitsubishi Tanabe unveils intravenous RADICAVA therapy in the US for treating amyotrophic lateral sclerosis. |
|
|
Aug 9, 2017 |
240 |
| Mitsubishi Tanabe unveils intravenous RADICAVA therapy in the US for treating amyotrophic lateral sclerosis. |
|
|
Aug 9, 2017 |
236 |
| New ALS drug therapy. |
|
|
Aug 1, 2017 |
260 |
| H. Lundbeck reports approval by US FDA of Abilify Maintena for extended-release injectable suspension for maintenance monotherapy treatment of bipolar I disorder (BP I) in adults. |
|
|
Jul 31, 2017 |
252 |
| H. Lundbeck reports approval by US FDA of Abilify Maintena for extended-release injectable suspension for maintenance monotherapy treatment of bipolar I disorder (BP I) in adults. |
|
|
Jul 31, 2017 |
248 |
| Glutamate's exciting roles in body, brain, and mind: a fertile future pharmacotherapy target. |
Nasrallah, Henry A. |
Editorial |
Jul 1, 2017 |
1504 |
| Mind Games: Researchers are reaching for new levels using video games technology for dementia treatments. |
Stempak, Nicole |
|
Jun 22, 2017 |
1300 |
| Wilson Therapeutics announces US Orphan Drug Designation receipt for WTX101 to treat ALS. |
|
|
Jun 12, 2017 |
284 |
| Wilson Therapeutics announces US Orphan Drug Designation receipt for WTX101 to treat ALS. |
|
|
Jun 12, 2017 |
280 |
| VACCINATION STATUS OF THE CHILDREN WITH NEUROLOGICAL DISORDERS AND ASSOCIATED FACTORS. |
Kondolot, Meda; Bayram, Ayse Kacar; Canpolat, Mehmet; Karakas, Faruk; Elmali, Ferhan; Gumus, Hakan; |
Report |
Mar 1, 2017 |
430 |
| Three-Dimensional Organoid System Transplantation Technologies in Future Treatment of Central Nervous System Diseases. |
Wei, NaiLi; Quan, ZiFang; Tang, Hailiang; Zhu, JianHong |
Report |
Jan 1, 2017 |
9415 |
| Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis. |
Kimura, Atsuko; Namekata, Kazuhiko; Guo, Xiaoli; Noro, Takahiko; Harada, Chikako; Harada, Takayuki |
Report |
Jan 1, 2017 |
6022 |
| Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia. |
Wu, Peng; Luo, Yuandai; Zhen, Lifang; Hu, Xianda; Shang, Ying; Liao, Yinuo; Xue, Huiyuan; Huang, Fuk |
|
Jan 1, 2016 |
6971 |
| Scientists Identify New Drug Target to Treat ALS. |
|
|
Jun 10, 2015 |
469 |
| Remission of episodic sweating attacks and comorbid depression in shapiro syndrome: case report/Shapiro sendromunda terleme ataklarinin ve komorbid depresyonun amitriptilin tedavisi ile remisyonu: olgu sunumu. |
Zincir, Selma Bozkurt; Zincir, Serkan; Kabak, Sevgi Gul |
Clinical report |
Dec 1, 2014 |
1341 |
| Enhancing spatial memory: anxiolytic and antidepressant effects of Tapinanthus dodoneifolius (DC) Danser in mice. |
Simplice, Foyet Harquin; Emery, Tsala David; Herve, Ngatanko Abaissou Herve |
Report |
Jan 1, 2014 |
6246 |
| Stretch-induced nerve injury: a proposed technique for the study of nerve regeneration and evaluation of the influence of gabapentin on this model. |
Machado, J.A.; Ghizoni, M.F.; Bertelli, J.; Teske, Gabriel C.; Teske, Guilherme C.; Martins, D.F.; M |
Report |
Nov 1, 2013 |
4428 |
| Skin cells transformed into brain cells: promising path to better Parkinson's treatment. |
|
|
Jul 30, 2012 |
775 |
| Promising path to better Parkinson's treatment. |
|
|
Jul 23, 2012 |
771 |
| New drug targets to treat debilitating nervous system disease identified. |
|
|
Oct 17, 2011 |
361 |
| DHEA/Pregnenolone. |
|
Report |
Jul 1, 2011 |
1379 |
| Tx for pseudobulbar affect. |
|
Column |
May 1, 2011 |
761 |
| Early antibiotic treatment in a child with PANDAS: a case report/PANDAS tanili bir cocukta erken antibiyotik tedavisi bir olgu sunumu. |
Ayaydin, Hamza; Abali, Osman |
Case study |
Jun 1, 2010 |
1185 |
| Steroids for lumbar radiculopathy. |
Ebbert, Jon O.; Tangalos, Eric G. |
Clinical report |
Sep 15, 2009 |
863 |
| Lineage 2 West Nile virus as cause of fatal neurologic disease in horses, South Africa. |
Venter, Marietjie; Human, Stacey; Zaayman, Dewald; Gerdes, Gertruida H.; Williams, June; Steyl, Joha |
Report |
Jun 1, 2009 |
5791 |
| Centella asiatica water extract inhibits [iPLA.sub.2] and [cPLA.sub.2] activities in rat cerebellum. |
Barbosa, N.R.; Pittella, F.; Gattaz, W.F. |
Report |
Oct 1, 2008 |
2818 |
| Tamiflu tied to pediatric neuropsychiatric events. |
Mechcatie, Elizabeth |
Clinical report |
Dec 1, 2006 |
620 |
| Oral as good as intramuscular vitamin [B.sub.12] replacement. |
|
|
Nov 1, 2006 |
340 |
| Neurologic disorders are high priority in R&D efforts. |
|
|
Aug 28, 2006 |
492 |
| Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca. |
Herrera-Ruiz, M.; Jimenez-Ferrer, J.E.; De Lima, T.C.M.; Aviles-Montes, D.; Perez-Garcia, D.; Gonzal |
Clinical report |
Jan 1, 2006 |
3480 |
| Cryptome to apply its drug discovery technology to neuroinflammatory diseases. |
|
|
Dec 1, 2004 |
380 |
| New roles for lamotrigine. |
Hinkle, Janice L. |
Brief Article |
Feb 1, 2004 |
178 |
